Rebordosa C, Plana E, Rubino A, Aguado J, Martinez D, Lei A, Daoud S, Saigi-Morgui N, Perez-Gutthann S, Rivero-Ferrer E. Risk assessment of acute myocardial infarction and stroke associated with long-acting muscarinic antagonists, alone or in combination, versus long-acting beta2-agonists. Int J Chron Obstruct Pulmon Dis. 2022 Aug 2;17:1715-33. doi: 10.2147/COPD.S363997
Rebordosa C, Plana E, Rubino A, Aguado J, Lei A, Daoud S, Saigi-Morgui N, Perez-Gutthann S, Rivero-Ferrer E. A cohort study to evaluate the risk of hospitalisation for congestive heart failure associated with the use of aclidinium and other chronic obstructive pulmonary disease medications in the UK Clinical Practice Research Datalink. Int J Chron Obstruct Pulmon Dis. 2021 May 31;16:1461-75. doi: 10.2147/COPD.S301624
Donohue IF, Bollu VK, Stull DE, Nelson LM, Williams VS, Stensland MD, Hanania NA. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial. Int J Chron Obstruct Pulmon Dis. 2018 Feb 5;13:499-508.
Wilson MR, Patel JG, Coleman A, McDade CL, Stanford RH, Earnshaw SR. Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model. Int J Chron Obstruct Pulmon Dis. 2017 Mar 24;2017(12):997-1008.
Schwab P, Dhamane AD, Hopson SD, Moretz C, Annavarapu S, Burslem K, Renda A, Kaila S. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2017 Feb 23;12:735-44. doi: 10.2147/COPD.S112256
Dhamane AD, Schwab P, Hopson S, Moretz C, Annavarapu S, Burslem K, Renda A, Kaila S. Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016 Dec 22;12:115-22. doi: 10.2147/COPD.S114802
Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012 Jul 1;7:457-94.
Herring WL, Herrmann JW. The single-day surgery scheduling problem: sequential decision-making and threshold-based heuristics. OR spectrum: quantitative approaches in management. 2012 Apr 1;34(2):429-59.
Dalal AA, Demuro-Mercon C, Lewis S, Nelson L, Gilligan T, McLeod L. Validation of alternate modes of administration of the lung function questionnaire (LFQ) in subjects with smoking history. Int J Chron Obstruct Pulmon Dis. 2010 Dec 1;5:425-34.
McKenna SP, Doward LC, van Assche D. Diabetic foot ulcers: a patients' perspective. Proc Br Psychol Soc. 2001;9(1):70.
McKenna SP, Whalley D, Doward LC. No SF-36 please – we're British!. Proc Br Psychol Soc. 2001;9(1):70.
Whalley D, Doward LC, McKenna SP. Urogenital atrophy: an accepted part of ageing? Proc Br Psychol Soc. 2001;9(1):78.
Doward LC, Whalley D, McKenna SP. The development of the Alzheimer's Carers Quality of Life Instrument (ACQLI). Proc Br Psychol Soc. 2001;9(1):65.
Doward LC, Whalley D, McKenna SP. Silent voices – hidden lives. Carer's perceptions of the impact of caring for a relative with Alzheimer's disease. Proc Br Psychol Soc. 2001;9(1):65.
Cook SA, Doward LC, McKenna SP, Erdman R, Niero M, van Assche D. Venous leg ulcers – patient-reported impact on quality of life. Proc Br Psychol Soc. 2001;9(1):64.
Dewar Al, Doward LC, Whalley D, McKenna SP, Tennant A, Emery P. Impact of systemic lupus erythematosus (SLE) experienced from the patients' perspective. Proc Br Psychol Soc. 2001;9(1):64.